After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at
Cellular immune responses against HCV: T cells take a diversion in the liver
✍ Scribed by Paul Klenerman; Nasser Semmo; Scott Ward
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 105 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Antitumor immunity against a fibrosarcoma in C57BL/6 mice was obtained by means of a semi‐allogenic somatic hybrid cell derived from the fusion of this C57BL/6 fibrosarcoma (MCB6‐1) and A9 cells of C3H origin. In a Winn assay, this immunity could be transferred by T lymphocytes to norma
## Abstract Immunocompetent lymphoid cells cultured in vitro with allogeneic stimulator cells have been shown to produce T‐lymphocyte populations which are specifically cytotoxic in vitro to the stimulatory cells whether normal or malignant. Although the culture requirements as well as the allogene
Virus-specific CD8+ T cells play a major role in antiviral immune defenses; their significance in the transplant setting, however, is unclear. In the present study, we asked whether hepatitis C virus (HCV)-specific CD8+ T cells were detectable in the presence of an immunosuppressive treatment and wh
## Abstract Hepatitis C virus (HCV) RNA persistence in the liver has been described even after apparent resolution of HCV infection. Because T‐cell reactivity plays a role in recovery from HCV infection, virus‐specific T‐cell responses were investigated in apparently recovered individuals in whom h